| Hans-Günter Meyer-Thompson | Fachartikel
Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate.
Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate.
Hsu CW, Yang WW, Hou CY, Feng IJ, Huang TY, Lee PL, Guo HR, Huang CY, Su SB.
Life (Basel). 2023 Dec 11;13(12):2326. doi: 10.3390/life13122326. PMID: 38137927; PMCID: PMC10745044.